Joycelyn J. X. Lee - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2015	1
2016	1
2020	2
2021	0

Page 1

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.

Ng HHM, Lee RY, Goh S, Tay ISY, Lim X, Lee B, Chew V, Li H, Tan B, Lim S, Lim JCT, Au B, Loh JJH, Saraf S, Connolly JE, Loh T, Leow WQ, Lee JJX, Toh HC, Malavasi F, Lee SY, Chow P, Newell EW, Choo SP, Tai D, Yeong J, Lim TKH. Ng HHM, et al. J Immunother Cancer. 2020 Aug;8(2):e000987. doi: 10.1136/jitc-2020-000987. J Immunother Cancer. 2020. PMID: 32847986 Free PMC article.

Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.

Ng KYY, Wong LWJ, Ang AJS, Tan SH, Choo SP, Tai DW, Lee JJX. Ng KYY, et al. Asia Pac J Clin Oncol. 2020 Sep 1. doi: 10.1111/ajco.13454. Online ahead of print. Asia Pac J Clin Oncol. 2020. PMID: 32875742

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma.

Lee JJX, Chan JJ, Choo SP. Lee JJX, et al. Diseases. 2015 Oct 28;3(4):306-324. doi: 10.3390/diseases3040306. Diseases. 2015. PMID: 28943627 Free PMC article. Review.

Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma.

Lee JJ, Chan A, Tang T. Lee JJ, et al. Acta Oncol. 2016;55(4):519-20. doi: 10.3109/0284186X.2015.1125017. Epub 2016 Jan 12. Acta Oncol. 2016. PMID: 26754959 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results